1 – 10 of 63
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Effectiveness and infectious complications of BCMA T-cell engagers in treating multiple myeloma : Real-world evidence from Sweden
Uttervall, Katarina ; Tätting, Love ; Lemonakis, Konstantinos LU ; Majd, Mousa ; Crafoord, Jacob ; Olsson, Mikael ; Mellqvist, Ulf Henrik ; Hansson, Markus LU
and Nahi, Hareth
(2024)
In Cancer Medicine
13(8).
- Contribution to journal › Article
- 2023
-
Mark
Abstract 5710: Detection and monitoring of t(11;14) in liquid biopsies from patients with relapsed/refractory multiple myeloma treated with venetoclax-based regimens
Li, Xiaotong ; Saal, Lao LU
; Brueffer, Christian
LU
; Chen, Yilun
LU
; Asklin, Johanna
LU
; Alvi, Saman
; Venkatram, Srinivas
and Ross, Jeremy
(2023)
AACR Annual Meeting 2023
In Cancer Research
83(7_Supplement).
- Contribution to journal › Published meeting abstract
-
Mark
Impact of 1q gains on treatment outcomes of patients with newly diagnosed multiple myeloma in a real-world Swedish population receiving modern treatment
Lemonakis, Konstantinos LU ; Olsson-Arvidsson, Linda LU ; Karlsson, Conny ; Johansson, Bertil LU and Hansson, Markus LU
(2023)
In European Journal of Haematology
111(3).
p.391-399
- Contribution to journal › Article
-
Mark
Neutrophils as Suppressor Cells and their role in Multiple Myeloma
(2023) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Computed tomography with adjusted dose for body mass index may be superior to whole-body radiography especially in elderly patients with multiple myeloma
Weber, Lars LU ; Hansson, Markus LU
and Geijer, Mats
LU
(2023)
In Acta Radiologica
64(5).
p.1896-1903
- Contribution to journal › Article
- 2022
-
Mark
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries
- Contribution to journal › Article
-
Mark
Genetic Predisposition to Sporadic and Familial Multiple Myeloma
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma : A randomised phase 2 trial by the Nordic Myeloma Study Group
- Contribution to journal › Article
-
Mark
Regional differences in treatment and outcome for myeloma patients in Sweden : A population based Swedish myeloma register study
- Contribution to journal › Article
-
Mark
Genetic predisposition for Multiple Myeloma. Identification and functional characterization of risk variants
(2022) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)